Tech Company Financing Transactions

OphthoTech Funding Round

Biogen Idec, HBM Healthcare Investments and Novo Ventures participated in a $24.5 million funding round for OphthoTech. The round was announced on 6/30/2008.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

1 Penn Plz. 3520
New York, NY 10119
USA

Phone

(212) 845-8200

Website

www.ophthotech.com

Email Address

[email protected]

Overview

Ophthotech Corporation (NASDAQ: OPHT) is a biopharmaceutical company focusing on discovering, developing and commercializing first-in-class therapies for the treatment of major ophthalmic diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Glenn Sblendorio

        

Chief Financial Officer

David Carroll

        

Chief Medical Officer

Kourous Rezaei

        

Chief Operating Officer

Evelyn Harrison

        

Chief Operating Officer

Keith Westby

        

VP - General Counsel

Todd Anderman

        

VP - Human Resources

Amy Sheehan

        

Browse more venture capital transactions:

Prev: 6/30/2008: Vmedia Research venture capital transaction
Next: 6/30/2008: DigitalSports venture capital transaction

Share this article

News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary